These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1995887)

  • 1. Renin inhibitory peptides. Incorporation of polar, hydrophilic end groups into an active renin inhibitory peptide template and their evaluation in a human renin infused rat model and in conscious sodium-depleted monkeys.
    Thaisrivongs S; Pals DT; DuCharme DW; Turner SR; DeGraaf GL; Lawson JA; Couch SJ; Williams MV
    J Med Chem; 1991 Feb; 34(2):633-42. PubMed ID: 1995887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.
    Thaisrivongs S; Pals DT; Harris DW; Kati WM; Turner SR
    J Med Chem; 1986 Oct; 29(10):2088-93. PubMed ID: 3531518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An orally active inhibitor of renin.
    Pals DT; Thaisrivongs S; Lawson JA; Kati WM; Turner SR; DeGraaf GL; Harris DW; Johnson GA
    Hypertension; 1986 Dec; 8(12):1105-12. PubMed ID: 3539793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.
    Thaisrivongs S; Pals DT; Lawson JA; Turner SR; Harris DW
    J Med Chem; 1987 Mar; 30(3):536-41. PubMed ID: 3546690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent renin inhibitory peptides containing hydrophilic end groups.
    Bundy GL; Pals DT; Lawson JA; Couch SJ; Lipton MF; Mauragis MA
    J Med Chem; 1990 Aug; 33(8):2276-83. PubMed ID: 2197413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and renal haemodynamic effects of renin or angiotensin converting enzyme inhibition in non-human primates.
    Pals DT; Ludens JH; DeGraaf GL
    J Hypertens Suppl; 1989 Apr; 7(2):S43-6. PubMed ID: 2666613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renin inhibition in the conscious primate Macaca fascicularis.
    Hui KY; Knight DR; Nussberger J; Hartley LH; Vatner SF; Haber E
    Hypertension; 1989 Nov; 14(5):480-7. PubMed ID: 2680962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a sensitive activity assay for high-volume evaluation of human renin inhibitory peptides in rat serum: results with U-71,038.
    Ruwart MJ; Sharma SK; Harris DW; Lakings DB; Rush BD; Wilkinson KF; Cornette JC; Evans DB; Friis JM; Cook KJ
    Pharm Res; 1990 Apr; 7(4):407-10. PubMed ID: 2194200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of rat renin inhibitory peptides.
    Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
    J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.
    Raddatz P; Jonczyk A; Minck KO; Schmitges CJ; Sombroek J
    J Med Chem; 1991 Nov; 34(11):3267-80. PubMed ID: 1956045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water-soluble renin inhibitors: design of a subnanomolar inhibitor with a prolonged duration of action.
    Rosenberg SH; Woods KW; Sham HL; Kleinert HD; Martin DL; Stein H; Cohen J; Egan DA; Bopp B; Merits I
    J Med Chem; 1990 Jul; 33(7):1962-9. PubMed ID: 2194033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
    Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
    J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appraisal of a glycopeptide cloaking strategy for a therapeutic oligopeptide: glycopeptide analogs of the renin inhibitor ditekiren.
    Harrison AW; Fisher JF; Guido DM; Couch SJ; Lawson JA; Sutter DM; Williams MV; DeGraaf GL; Rogers JE; Pals DT
    Bioorg Med Chem; 1994 Dec; 2(12):1339-61. PubMed ID: 7788297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of novel imidazole alcohol inhibitors of primate renin.
    DeForrest JM; Waldron TL; Oehl RS; Scalese RJ; Free CA; Weller HN; Ryono DE
    J Hypertens Suppl; 1989 Apr; 7(2):S15-9. PubMed ID: 2666607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CP-71,362: a pentapeptide renin inhibitor selective for the canine enzyme.
    Mangiapane ML; MacAndrew JT; Ellery SS; Smith AH; Purcell IM; Kleinman EF; Holt WF; Murphy WR
    Clin Exp Hypertens; 1994 Jul; 16(4):507-33. PubMed ID: 7920458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
    Burton J; Cody RJ; Herd JA; Haber E
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of potent substrate-analogue inhibitors of canine renin.
    Hui KY; Siragy HM; Haber E
    Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.
    Hui KY; Carlson WD; Bernatowicz MS; Haber E
    J Med Chem; 1987 Aug; 30(8):1287-95. PubMed ID: 3302256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity.
    Kleinert HD; Martin D; Chekal MA; Kadam J; Luly JR; Plattner JJ; Perun TJ; Luther RR
    Hypertension; 1988 Jun; 11(6 Pt 2):613-9. PubMed ID: 3292414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.